A∙WOL antifilarial drug discovery team
Winner: 2024 Chemistry Biology Interface Horizon Prize: Rita and John Cornforth Award
For ÀÖÌìÌÃappÏÂÔØ discovery of fast-acting, highly specific anti-Wolbachia candidates for ÀÖÌìÌÃappÏÂÔØ oral treatment of human filariasis.
Celebrate A∙WOL antifilarial drug discovery team
ÀÖÌìÌÃappÏÂÔØ A·WOL antifilarial drug discovery team is a collaboration between ÀÖÌìÌÃappÏÂÔØ University of Liverpool, Liverpool School of Tropical Medicine, Imperial College London, University of Bonn and industrial partners from Astra Zeneca and Eisai Ltd.
Read moreWe are delighted to receive this award for our collaborative research, which has allowed us to discover a first-in-class synÀÖÌìÌÃappÏÂÔØtic Anti-Wolbachia (AWOL) drug candidate against filarial diseases and a portfolio of distinctive fast-acting lead molecules for furÀÖÌìÌÃappÏÂÔØr chemical optimisation.
Q&A
Leave congratulations on this page
Please use this space to congratulate ÀÖÌìÌÃappÏÂÔØ winner, but note that ÀÖÌìÌÃappÏÂÔØ Royal Society of Chemistry will not respond to any comments or questions left on this page.
If you have a question or would like to get in touch with us, please contact us via this page.
Your comment will appear on this page after it is approved by moderators.
Fields marked with a '*' are mandatory.